Michael Scott Mann - Net Worth and Insider Trading
Michael Scott Mann Net Worth
The estimated net worth of Michael Scott Mann is at least $651 Million dollars as of 2024-04-16. Michael Scott Mann is the President, 10% Owner of Eni SpA and owns about 20,217,849 shares of Eni SpA (E) stock worth over $651 Million. Michael Scott Mann is also the President of Endonovo Therapeutics Inc and owns about 26,789 shares of Endonovo Therapeutics Inc (ENDV) stock worth over $86. Details can be seen in Michael Scott Mann's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael Scott Mann has not made any transactions after 2019-03-29 and currently still holds the listed stock(s).
Transaction Summary of Michael Scott Mann
Michael Scott Mann Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Scott Mann owns 1 companies in total, including Endonovo Therapeutics Inc (ENDV) .
Click here to see the complete history of Michael Scott Mann’s form 4 insider trades.
Insider Ownership Summary of Michael Scott Mann
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ENDV | Endonovo Therapeutics Inc | 2019-03-29 | 10 percent owner & President |
Michael Scott Mann Latest Holdings Summary
Michael Scott Mann currently owns a total of 2 stocks. Among these stocks, Michael Scott Mann owns 20,217,849 shares of Eni SpA (E) as of April 18, 2017, with a value of $651 Million and a weighting of 100%. Michael Scott Mann also owns 26,789 shares of Endonovo Therapeutics Inc (ENDV) as of March 29, 2019, with a value of $86 and a weighting of 0%.
Latest Holdings of Michael Scott Mann
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| E | Eni SpA | 2017-04-18 | 20,217,849 | 32.22 | 651,419,095 |
| ENDV | Endonovo Therapeutics Inc | 2019-03-29 | 26,789 | 0.00 | 86 |
Holding Weightings of Michael Scott Mann
Michael Scott Mann Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Scott Mann has made a total of 0 transactions in Eni SpA (E) over the past 5 years. The most-recent trade in Eni SpA is the acquisition of 12,000 shares on April 18, 2017, which cost Michael Scott Mann around $1,320.
According to the SEC Form 4 filings, Michael Scott Mann has made a total of 0 transactions in Endonovo Therapeutics Inc (ENDV) over the past 5 years. The most-recent trade in Endonovo Therapeutics Inc is the acquisition of 5 shares on March 29, 2019, which cost Michael Scott Mann around $100.
Insider Trading History of Michael Scott Mann
- 1
Michael Scott Mann Trading Performance
GuruFocus tracks the stock performance after each of Michael Scott Mann's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Scott Mann is 12.71%. GuruFocus also compares Michael Scott Mann's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Scott Mann within 3 months outperforms 79 times out of 236 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Scott Mann's insider trading performs compared to the benchmark.
Performance of Michael Scott Mann
Average Relative Return
-30.8%
Outperforming Transactions
20%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | 7.77 | 12.71 | 4.66 | -30.8 | -64 | -85.19 |
| Relative Return to S&P 500(%) | 6.68 | 10.05 | -1.32 | -41.01 | -73.63 | -96.65 |
Michael Scott Mann Ownership Network
Ownership Network List of Michael Scott Mann
Ownership Network Relation of Michael Scott Mann
Michael Scott Mann Owned Company Details
What does Endonovo Therapeutics Inc do?
Who are the key executives at Endonovo Therapeutics Inc?
Michael Scott Mann is the 10 percent owner & President of Endonovo Therapeutics Inc. Other key executives at Endonovo Therapeutics Inc include and director & 10 percent owner & CEO Alan Brian Collier .
Endonovo Therapeutics Inc (ENDV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Endonovo Therapeutics Inc (ENDV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Endonovo Therapeutics Inc (ENDV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Endonovo Therapeutics Inc (ENDV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Endonovo Therapeutics Inc Insider Transactions
Michael Scott Mann Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Scott Mann. You might contact Michael Scott Mann via mailing address: 6320 Canoga Avenue, Woodland Hills Ca 91367.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
